Exciting new findings indicate that GLP-1 weight-loss medications might dramatically reduce the likelihood of 10 types of cancer linked to obesity for patients with type 2 diabetes, outperforming insulin. However, there’s no observed benefit for postmenopausal breast or thyroid cancers.
Related Posts
Ageless Djokovic outlasts Alcaraz to make Aus Open semis
Novak Djokovic, at 37, defeated Carlos Alcaraz in the Australian Open quarter-final despite his injury, advancing to the semi-finals for the 12th time. Djokovic’s 4-6, […]
LLB student dies after falling from 7th floor at friend’s party in Noida
A 23-year-old Amity University student fell to his death from the seventh floor of a condominium in Noida during a party. Police suspect involvement of […]
Chinnaswamy reopens for cricket, RCB to host IPL matches
The Karnataka cabinet approved the return of cricket to Bengaluru’s M Chinnaswamy Stadium, clearing RCB to host IPL matches again after a ban following the […]